Lv2
126 积分 2022-06-16 加入
Triple M overlap syndrome following pembrolizumab treatment: importance of multidisciplinary approach
11小时前
已完结
Triple M syndrome (myasthenia gravis, myocarditis and myositis) following atezolizumab in small cell lung carcinoma
12小时前
已完结
Effets secondaires inhabituels des immunothérapies dans le cancer bronchique non à petites cellules : à propos de deux cas
13小时前
已完结
Nivolumab- and ipilimumab-induced myositis, myasthenia gravis, and myocarditis in a patient with metastatic melanoma
1个月前
已完结
Autologous tumor cell–derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion
1个月前
已完结
Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation
2个月前
已完结
A case report and literature review on respiratory failure with immune checkpoint inhibitors: a life-threatening adverse event
2个月前
已完结
Anti-PD-1 and Regorafenib Induce Severe Multisystem Adverse Events in Microsatellite Stability Metastatic Colorectal Cancer: A Case Report
2个月前
已完结
Pembrolizumab-induced myocarditis, myositis, and myasthenia gravis overlap syndrome (IM3OS) treated with Efgartigimod: case report
2个月前
已完结
YAP1 Suppression by ZDHHC7 Is Associated with Ferroptosis Resistance and Poor Prognosis in Ovarian Clear Cell Carcinoma
3个月前
已完结
皖公网安备34019202002308
